Electronic Health Record (EHR)-Based Intervention for gastroesophageal reflux disease (GERD) and Chronic non-steroidal anti-inflammatory drug (NSAID) Use
Study identifier:NIS-GUS-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Using an electronic health record-based intervention and broad education reach strategies to improve quality of care for GERD and gastroprotection for patients on NSAIDs: a randomized controlled trial
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
5234
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2007
Primary Completion Date: 01 Jun 2008
Study Completion Date: 01 Jun 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Apr 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 GERD: Patients with established diagnoses of GERD based on ICD-9 codes | - |
| 2 Atypical GERD: Patients without an established diagnosis of GERD with atypical symptoms that could be due to GERD (e.g., asthma) | - |
| 3 Chronic NSAID users: Patients using chronic NSAIDs who are at increased risk of GI complications (defined as previous diagnosis of peptic ulcer disease; age 75 or older; or concomitant use of corticosteroids, anticoagulants, or aspirin) | - |
Contacts
Investigators
Principal Investigator
James M Gill
Delaware Valley Outcomes Research
